Newly developed gene classifier identifies risk of pre-breast cancer progression

byDuke University Medical CenterCohorts and methods outline. Two retrospective study cohorts were generated, consisting of ductal carcinoma in situ (DCIS) patients with either a subsequent ipsil

Updated on: January 13,2024

Newly developed gene classifier identifies risk of pre-breast cancer progression

byDuke University Medical CenterCohorts and methods outline. Two retrospective study cohorts were generated, consisting of ductal carcinoma in situ (DCIS) patients with either a subsequent ipsil

Updated on:January 13,2024

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Updated on: August 27,2024

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Updated on:August 27,2024

Adhering to global health recommendations reduces cancer risk

byNewcastle UniversityCredit: CC0 Public DomainPeople who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms

Updated on: January 22,2024

Adhering to global health recommendations reduces cancer risk

byNewcastle UniversityCredit: CC0 Public DomainPeople who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms

Updated on:January 22,2024

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on: August 03,2024

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on:August 03,2024

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when

Updated on: April 07,2024

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when

Updated on:April 07,2024

Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

JANUARY 26, 2024by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainPatients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new t

Updated on: March 30,2024

Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

JANUARY 26, 2024by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainPatients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new t

Updated on:March 30,2024

An under-the-radar immune cell shows potential in fight against cancer

by University of British ColumbiaCredit: CC0 Public DomainOne of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreadin

Updated on: May 20,2024

An under-the-radar immune cell shows potential in fight against cancer

by University of British ColumbiaCredit: CC0 Public DomainOne of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreadin

Updated on:May 20,2024

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret

Updated on: March 01,2024

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret

Updated on:March 01,2024

Boosting T cell 'memory' may result in longer-lasting and effective responses for patients

by University of Texas M. D. Anderson Cancer CenterScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDJust like pe

Updated on: April 18,2024

Boosting T cell 'memory' may result in longer-lasting and effective responses for patients

by University of Texas M. D. Anderson Cancer CenterScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDJust like pe

Updated on:April 18,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on: March 06,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on:March 06,2024

Study highlights how lower-income, working cancer caregivers experience harder financial impacts

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainCancer is a disease of ripples—from symptoms that precede a diagnosis to treatment, side effects, and goals for long-te

Updated on: February 18,2024

Study highlights how lower-income, working cancer caregivers experience harder financial impacts

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainCancer is a disease of ripples—from symptoms that precede a diagnosis to treatment, side effects, and goals for long-te

Updated on:February 18,2024

Researchers identify potential target in myeloid malignancies

by Children's Hospital of PhiladelphiaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI165510Researchers at Children's Hospital of Philadelp

Updated on: February 18,2024

Researchers identify potential target in myeloid malignancies

by Children's Hospital of PhiladelphiaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI165510Researchers at Children's Hospital of Philadelp

Updated on:February 18,2024